879: DEVELOPMENT OF A PHARMACIST-MANAGED PROTOCOL FOR TRANSITION FROM INTRAVENOUS TO SUBCUTANEOUS INSULIN

Abstract #162: Dramatic Reduction in Insulin Requirement after Starting Continuous Subcutaneous Insulin Infusion Using U500 Insulin in a Patient With Type 2 Diabetes and Severe Insulin Resistance

Endocrine Practice ◽

10.1016/s1530-891x(20)43960-6 ◽

2006 ◽

Vol 12 ◽

pp. 10

Author(s):

Thottathil Gopan ◽

Elias Siraj

Keyword(s):

Insulin Resistance ◽

Type 2 Diabetes ◽

Insulin Infusion ◽

Insulin Requirement ◽

Dramatic Reduction ◽

Subcutaneous Insulin ◽

Severe Insulin Resistance

IV to Subcutaneous Insulin: Methods Vary

Hospitalist News ◽

10.1016/s1875-9122(11)70134-1 ◽

2011 ◽

Vol 4 (7) ◽

pp. 6-7

Author(s):

MICHELE G. SULLIVAN

Keyword(s):

Long-term results of continuous subcutaneous insulin infusion on glycemic control and severe hypoglycemias

Endocrine Abstracts ◽

10.1530/endoabs.56.p517 ◽

2018 ◽

Author(s):

Vale Sonia do ◽

Raquel Carvalho ◽

Tania Matos ◽

Cristiana Costa ◽

Martins Ana Filipa ◽

...

Keyword(s):

Glycemic Control ◽

Insulin Infusion ◽

Long Term Results ◽

Use of Long-Acting Subcutaneous Insulin in Management of Neonatal Hyperglycemia in Extremely Low Birth Weight Infant

PEDIATRICS ◽

10.1542/peds.137.supplement_3.401a ◽

2016 ◽

Vol 137 (Supplement 3) ◽

pp. 401A-401A

Author(s):

Min J. Hwang ◽

Robert J. Newman ◽

Elizabeth Y. Flanigan

Keyword(s):

Birth Weight ◽

Low Birth Weight ◽

Extremely Low Birth Weight ◽

Subcutaneous Insulin ◽

Low Birth Weight Infant ◽

Neonatal Hyperglycemia ◽

Long Acting

Simplified Transition Algorithm from Intravenous to Subcutaneous Insulin in Nondiabetic Cardiac Surgery Patients with Stress Hyperglycemia

Diabetes ◽

10.2337/db18-1237-p ◽

2018 ◽

Vol 67 (Supplement 1) ◽

pp. 1237-P ◽

Cited By ~ 1

Author(s):

SAUMETH CARDONA ◽

RODOLFO J. GALINDO ◽

KATERINA G. TSEGKA ◽

MARIA A. URRUTIA ◽

PRIYATHAMA VELLANKI ◽

...

Keyword(s):

Cardiac Surgery ◽

Subcutaneous Insulin ◽

Stress Hyperglycemia

1073-P: A Study of Flat and Circadian Insulin infusion Rates in Continuous Subcutaneous Insulin Infusion (CSII) in Adults with Type 1 Diabetes (FIRST1D)

Diabetes ◽

10.2337/db19-1073-p ◽

2019 ◽

Vol 68 (Supplement 1) ◽

pp. 1073-P

Author(s):

SIAN K. RILSTONE ◽

MONIKA REDDY ◽

NICK OLIVER

Keyword(s):

Type 1 Diabetes ◽

Insulin Infusion ◽

1062-P: Insulin Requirement Profiles of Short-Term Continuous Subcutaneous Insulin Infusion Therapy in Chinese Patients with Type 2 Diabetic Nephropathy

Diabetes ◽

10.2337/db19-1062-p ◽

2019 ◽

Vol 68 (Supplement 1) ◽

pp. 1062-P

Author(s):

SHUO LIN ◽

KUIXING ZHANG ◽

PING LI ◽

KE FANG ◽

LONGYI ZENG

Keyword(s):

Diabetic Nephropathy ◽

Insulin Infusion ◽

Insulin Requirement ◽

Chinese Patients ◽

Infusion Therapy ◽

Subcutaneous Insulin ◽

Short Term ◽

Type 2 Diabetic

Preferable Conversion Rate from Intravenous to Subcutaneous Insulin in Hyperglycemic Emergencies in Diabetic Patients

Diabetes ◽

10.2337/db18-2286-pub ◽

2018 ◽

Vol 67 (Supplement 1) ◽

pp. 2286-PUB

Author(s):

HIKARU TAKAMINE ◽

YULIA NAMIKI ◽

HIROKO HIIRAGI ◽

TAKU YAMADA ◽

YUYA TAKANO ◽

...

Keyword(s):

Conversion Rate ◽

Diabetic Patients ◽

Increase in insulin antibodies during continuous subcutaneous insulin infusion and multiple-injection therapy in contrast to conventional treatment

Diabetes ◽

10.2337/diabetes.36.1.1 ◽

1987 ◽

Vol 36 (1) ◽

pp. 1-5 ◽

Cited By ~ 8

Author(s):

K. Dahl-Jorgensen ◽

P. Torjesen ◽

K. F. Hanssen ◽

L. Sandvik ◽

O. Aagenaes

Keyword(s):

Conventional Treatment ◽

Insulin Infusion ◽

Insulin Antibodies ◽

Injection Therapy ◽

Subcutaneous Insulin ◽

Multiple Injection

No evidence of amyloidosis in type I diabetics treated with continuous subcutaneous insulin infusion

Diabetes ◽

10.2337/diabetes.32.1.88 ◽

1983 ◽

Vol 32 (1) ◽

pp. 88-90 ◽

Cited By ~ 3

Author(s):

V. A. Koivisto ◽

A. M. Teppo ◽

C. P. Maury ◽

M. R. Taskinen

Keyword(s):

Insulin Infusion ◽

Type I ◽